Stock Events

Stock Events

Atricure 

$52.40
17
-$0.06-0.12% 13:39 Today

Statistics

Day High
52.4
Day Low
52.17
52W High
52.59
52W Low
25.86
Volume
4,659
Avg. Volume
-
Mkt Cap
2.67B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.23
-0.09
0.04
0.18
Expected EPS
-0.042697
Actual EPS
N/A

Financials

-2.14%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
534.53MRevenue
-11.45MNet Income

Analyst Ratings

56.80Average Price Target
The highest estimate is 64.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ATRC. It's not an investment recommendation.
Johnson & Johnson
4
JNJ
Altria Group
4
MO
Verizon Communications
4
VZ
McDonald`s
4
MCD

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.77B
Medtronic offers a wide range of medical devices for cardiac and vascular surgeries, directly competing with AtriCure's atrial fibrillation products.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific competes in the cardiac surgery space, particularly with products for electrophysiology, which overlaps with AtriCure's offerings.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories provides medical devices, including heart monitors and ablation catheters, that compete with AtriCure's atrial fibrillation solutions.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its medical device division, offers products that compete in the surgical and cardiovascular arenas, similar to AtriCure's market.
Smith & Nephew
SNN
Mkt Cap12.12B
Smith & Nephew, while known for orthopedics, has been expanding into surgical devices that could compete with AtriCure's portfolio.
Edwards Lifesciences
EW
Mkt Cap52B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, which places it in competition with AtriCure for certain cardiac surgery applications.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet, primarily focused on musculoskeletal healthcare, has been venturing into surgical solutions that could overlap with AtriCure's market.
Stryker
SYK
Mkt Cap126.84B
Stryker focuses on a broad range of medical technologies, including surgical equipment that could compete with AtriCure's offerings.
Intuitive Surgical
ISRG
Mkt Cap131.63B
Intuitive Surgical, known for its da Vinci surgical systems, competes in the broader surgical device market, impacting companies like AtriCure that offer surgical solutions.

About

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Show more...
CEO
Michael H. Carrel
Employees
1350
Country
United States
ISIN
US04963C2098
WKN
000A0ES9W

Listings

F
DE
A5I.F
XNAS
US
ATRC
BOATS
BOATS
ATRC.BOATS

0 Comments

Share your thoughts

FAQ

What is Atricure stock price today?▼
The current price of ATRC is $52.40 USD — it has decreased by -0.12% in the past 24 hours. Watch Atricure stock price performance more closely on the chart.
What is Atricure stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Atricure stocks are traded under the ticker ATRC.
Is Atricure stock price growing?▼
ATRC stock has risen by +7.9% compared to the previous week, the month change is a +34.29% rise, over the last year Atricure has showed a +46.87% increase.
What is Atricure market cap?▼
Today Atricure has the market capitalization of 2.67B
When is the next Atricure earnings date?▼
Atricure is going to release the next earnings report on November 04, 2026.
What were Atricure earnings last quarter?▼
ATRC earnings for the last quarter are 0.18 USD per share, whereas the estimation was -0 USD resulting in a +10,846.27% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Atricure revenue for the last year?▼
Atricure revenue for the last year amounts to 534.53M USD.
What is Atricure net income for the last year?▼
ATRC net income for the last year is -11.45M USD.
How many employees does Atricure have?▼
As of September 04, 2026, the company has 1,350 employees.
In which sector is Atricure located?▼
Atricure operates in the Health & Wellness sector.
When did Atricure complete a stock split?▼
Atricure has not had any recent stock splits.
Where is Atricure headquartered?▼
Atricure is headquartered in MASON, United States.